Prevalence of cardiovascular sequelae after COVID-19 - REBOUH, Amel Leila;AITSEDDIK, Sarah;Belkaid, Rosa
49,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
25 °P sammeln
  • Broschiertes Buch

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), called Coronavirus Disease 2019 (COVID-19) by the World Health Organization, was detected as a novel betacoronavirus infection in Wuhan, China on December 12, 2019 before spreading globally. More and more publications are finding cardiovascular lesions that were not present on admission.The question posed is: "Once recovered from COVID-19, what happens to patients cardiovascularly and what impact does the virus have on the cardiovascular system?".

Andere Kunden interessierten sich auch für
Produktbeschreibung
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), called Coronavirus Disease 2019 (COVID-19) by the World Health Organization, was detected as a novel betacoronavirus infection in Wuhan, China on December 12, 2019 before spreading globally. More and more publications are finding cardiovascular lesions that were not present on admission.The question posed is: "Once recovered from COVID-19, what happens to patients cardiovascularly and what impact does the virus have on the cardiovascular system?".
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
La Dra. Amel Leila REBOUH es licenciada por la Facultad de Medicina de Argel, donde imparte clases de Epidemiología y Medicina Preventiva desde 2018. Trabajó en el Institut National de Santé Publique antes de incorporarse al Centre Hospitalier Universitaire de Béni Messous.